Report cover image

BRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

Publisher MarketLine
Published Oct 25, 2023
Length 112 Pages
SKU # MTLN18362561

Description

BRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027


Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $289.7 billion in 2022. China was the fastest growing country with a CAGR of 12.2% over the 2018-22 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $213.2 billion in 2022. This was followed by Russia, India and Brazil with a value of $31.9, $24.2, and $20.4 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $355.2 billion in 2027, followed by Russia, India, Brazil with expected values of $40.0, $32.6 and $20.0 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to Buy
  • What was the size of the BRIC pharmaceuticals market by value in 2022?
  • What will be the size of the BRIC pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?

Table of Contents

112 Pages
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in India
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Russia
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Company Profiles
11.1. Ache Laboratorios Farmaceuticos SA
11.2. EMS Sigma Pharma
11.3. Yangtze River Pharmaceutical Group
11.4. Shanghai Pharmaceuticals Holding Co Ltd
11.5. Yunnan Baiyao Group Co Ltd
11.6. Guangzhou Pharmaceutical Holdings Ltd
11.7. Sun Pharmaceutical Industries Ltd
11.8. Lupin Ltd
11.9. Dr. Reddy's Laboratories Limited
11.10. Aurobindo Pharma Ltd
11.11. Novartis AG
11.12. Sanofi SA
11.13. Bayer AG
11.14. Les Laboratoires Servier
12 Appendix
12.1. Methodology
12.2. About MarketLine
List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2018-27
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2018-22
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2022-27
Table 4: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 6: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Table 7: Brazil size of population (million), 2018–22
Table 8: Brazil gdp (constant 2005 prices, $ billion), 2018–22
Table 9: Brazil gdp (current prices, $ billion), 2018–22
Table 10: Brazil inflation, 2018–22
Table 11: Brazil consumer price index (absolute), 2018–22
Table 12: Brazil exchange rate, 2018–22
Table 13: China pharmaceuticals market value: $ billion, 2017-22
Table 14: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 15: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 16: China size of population (million), 2018–22
Table 17: China gdp (constant 2005 prices, $ billion), 2018–22
Table 18: China gdp (current prices, $ billion), 2018–22
Table 19: China inflation, 2018–22
Table 20: China consumer price index (absolute), 2018–22
Table 21: China exchange rate, 2018–22
Table 22: India pharmaceuticals market value: $ billion, 2017-22
Table 23: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 24: India pharmaceuticals market value forecast: $ billion, 2022–27
Table 25: India size of population (million), 2018–22
Table 26: India gdp (constant 2005 prices, $ billion), 2018–22
Table 27: India gdp (current prices, $ billion), 2018–22
Table 28: India inflation, 2018–22
Table 29: India consumer price index (absolute), 2018–22
Table 30: India exchange rate, 2018–22
Table 31: Russia pharmaceuticals market value: $ billion, 2017-22
Table 32: Russia pharmaceuticals market geography segmentation: $ billion, 2022
Table 33: Russia pharmaceuticals market value forecast: $ billion, 2022–27
Table 34: Russia size of population (million), 2018–22
Table 35: Russia gdp (constant 2005 prices, $ billion), 2018–22
Table 36: Russia gdp (current prices, $ billion), 2018–22
Table 37: Russia inflation, 2018–22
Table 38: Russia consumer price index (absolute), 2018–22
Table 39: Russia exchange rate, 2018–22
Table 40: Ache Laboratorios Farmaceuticos SA: key facts
Table 41: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 42: EMS Sigma Pharma: key facts
Table 43: EMS Sigma Pharma: Key Employees
Table 44: Yangtze River Pharmaceutical Group: key facts
Table 45: Yangtze River Pharmaceutical Group: Key Employees
Table 46: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 47: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 48: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 49: Yunnan Baiyao Group Co Ltd: key facts
Table 50: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 51: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 52: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 53: Sun Pharmaceutical Industries Ltd: key facts
Table 54: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 55: Sun Pharmaceutical Industries Ltd: Key Employees
Table 56: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 57: Lupin Ltd: key facts
Table 58: Lupin Ltd: Annual Financial Ratios
Table 59: Lupin Ltd: Key Employees
Table 60: Dr. Reddy's Laboratories Limited: key facts
Table 61: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 62: Dr. Reddy's Laboratories Limited: Key Employees
Table 63: Aurobindo Pharma Ltd: key facts
Table 64: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 65: Aurobindo Pharma Ltd: Key Employees
Table 66: Novartis AG: key facts
Table 67: Novartis AG: Annual Financial Ratios
Table 68: Novartis AG: Key Employees
Table 69: Novartis AG: Key Employees Continued
Table 70: Sanofi SA: key facts
Table 71: Sanofi SA: Annual Financial Ratios
Table 72: Sanofi SA: Key Employees
Table 73: Sanofi SA: Key Employees Continued
Table 74: Bayer AG: key facts
Table 75: Bayer AG: Annual Financial Ratios
Table 76: Bayer AG: Key Employees
Table 77: Bayer AG: Key Employees Continued
Table 78: Les Laboratoires Servier: key facts
Table 79: Les Laboratoires Servier: Key Employees
List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2018-27
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2018-22
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2022-27
Figure 4: Brazil pharmaceuticals market value: $ billion, 2017-22
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 6: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Figure 7: Forces driving competition in the pharmaceuticals market in Brazil, 2022
Figure 8: Drivers of buyer power in the pharmaceuticals market in Brazil, 2022
Figure 9: Drivers of supplier power in the pharmaceuticals market in Brazil, 2022
Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2022
Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2022
Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2022
Figure 13: China pharmaceuticals market value: $ billion, 2017-22
Figure 14: China pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 15: China pharmaceuticals market value forecast: $ billion, 2022–27
Figure 16: Forces driving competition in the pharmaceuticals market in China, 2022
Figure 17: Drivers of buyer power in the pharmaceuticals market in China, 2022
Figure 18: Drivers of supplier power in the pharmaceuticals market in China, 2022
Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2022
Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2022
Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in China, 2022
Figure 22: India pharmaceuticals market value: $ billion, 2017-22
Figure 23: India pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 24: India pharmaceuticals market value forecast: $ billion, 2022–27
Figure 25: Forces driving competition in the pharmaceuticals market in India, 2022
Figure 26: Drivers of buyer power in the pharmaceuticals market in India, 2022
Figure 27: Drivers of supplier power in the pharmaceuticals market in India, 2022
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2022
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2022
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in India, 2022
Figure 31: Russia pharmaceuticals market value: $ billion, 2017-22
Figure 32: Russia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 33: Russia pharmaceuticals market value forecast: $ billion, 2022–27
Figure 34: Forces driving competition in the pharmaceuticals market in Russia, 2022
Figure 35: Drivers of buyer power in the pharmaceuticals market in Russia, 2022
Figure 36: Drivers of supplier power in the pharmaceuticals market in Russia, 2022
Figure 37: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2022
Figure 38: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2022
Figure 39: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us